SCH – Society of Comparative Hepatology 
Thursday 6 September 2018
09.00 Lawrence Development, validation, and application of an LC-MS/MS method for the quantitative determination of trans-4-hydroxy-l-proline in dogs with chronic hepatitis
09.15 Oliveira Leal Copper-associated Hepatitis in dogs: a retrospective study of 17 clinical cases
09.30 Sato Plasma renin activity and aldosterone concentration in primary hypoplasia of the portal vein with portal hypertension in dogs
09.45 Ambrosini Serum vitamin D, C-Reactive Protein, and von Willebrand’s factor in dogs with inflammatory hepatopathies
10.00 Ferreira Serum melatonin concentrations in dogs with congenital portosystemic shunts
ESVC – European Society of Veterinary Cardiology
Thursday 6 September 2018
14.25 Rishniw Echocardiographically obtained left-atrial-to-aortic ratio in healthy dogs: re-evaluation of historic reference intervals
14.40 Bouvard Comparison of ECG-gated multi-detector computed tomography angiography and two-dimensional echocardiographic methods in the assessment of left atrial size using left atrial-to-aortic root short-axis ratio in dogs
14.55 Bouvard Assessment of left atrial volume in dogs: comparisons of two-dimensional and real-time three-dimensional echocardiography with ECG-gated multi-detector computed tomography angiography
15.10 Novo Matos Post mortem assessment of left ventricular mass by micro-computed tomography in feline cardiomyopathic hearts
15.25 Beijerink ECG-gated computed tomography angiography of pulmonic stenosis in 31 dogs
15.40 Mateos Panero Radiofrequency catheter ablation of accessory pathways in the dog: the Italian experience (2008-2016)
15.55 Rishniw Breed does not affect the association between murmur intensity and disease severity in dogs with pulmonic or subaortic stenosis
16.10 Takano Breed characteristics in cardiac reverse remodeling and left ventricular systolic function after mitral valve repair in dogs
16.25 Betschart Iron deficiency assessment in dogs with chronic heart failure
Friday 7 September 2018
11.20 Stack Effects of oral trazodone on echocardiographic and hemodynamic measurements in healthy cats
11.35 Borgeat Prevalence of hypersomatotropism in non-diabetic cats with left ventricular hypertrophy – a silent and curable phenocopy for hypertrophic cardiomyopathy
11.50 Sebastian New genetic variants of MYH6 gene were associated with sporadic hypertrophic cardiomyopathy in cats
12.05 Liu Discovery of novel biomarkers for cardiomyopathies in cats with congestive heart failure
12.20 Hanås Effect of breed and signalment on N-terminal Prohormone of Brain Natriuretic Peptide concentrations measured by ELISA in healthy cats and comparison to a point of care test
12.35 Ivasovic Evaluation of NT-proBNP-levels in sport dogs after immediate physical activity and after an intense two months training session
14.25 Serres Interest of a cardiac troponin I using a bedside analyzer for clinical orientation in dogs with mitral insufficiency and/or dyspnea
14.40 Sarcinella Effect of pimobendan on left atrial function in dogs with stage B2 myxomatous mitral valve disease
14.55 Lee The misuse (overdose) of pimobendan may potentially induce myocardial fatigue in dogs with myxomatous mitral valve disease
15.10 Kiss Heart-specific and fibrosis related microRNAs in whole blood samples of dogs with cardiomyopathy
15.25 Saponaro Heart rhythm characterization by 24-hour Holter monitoring during sudden cardiac death in dogs – A case series
15.40 Perego R-peak time in normal dogs
ESVONC – European Society of Veterinary Oncology
Thursday 6 September 2018
14.25 Weber Tumor-specific microRNA expression in canine intestinal T-cell lymphomas and analysis of microRNA function in a canine T-cell lymphoma cell line
14.40 Treggiari Retrospective comparison of first line adjuvant anthracycline versus metronomic-based chemotherapy protocols in the treatment of stage i-ii, canine splenic haemangiosarcoma
14.55 Del Busto Castro Incidence of post-operative complications and outcome of 48 dogs undergoing surgical management of insulinoma
15.10 Holdsworth Owners’ perceptions of the treatment of Osteosarcoma in large breed dogs
15.25 McNaught Assessing serum clusterin as a potential biomarker for canine lymphoma
15.40 Queiroga TGFß, FOXP3 and angiogenesis in malignant canine mammary tumors: association with clinicopathological parameters and prognosis
16.10 Milevoj A combination of gene electrotransfer of canine IL-12, electrochemotherapy and cytoreductive surgery in the treatment of canine oral malignant melanoma
16.25 Kimura Evaluation of angiogenesis using semiquantitative RT-PCR for endothelial markers in various canine tumors
ESVIM – European Society of Veterinary Internal Medicine 
Friday 7 September 2018
09.00 Fastrès Effect of antimicrobial drug on lung microbiota in healthy dogs
09.15 Carranza Comparison of the pulmonary deposition of nebulized 99mTc-DTPA through three different inhalation devices in healthy dogs
09.30 Cui Long-term survival and complications in end-stage tracheal collapse dogs treated with intraluminal self-expanding Wallstents™
09.45 Dominguez Ruiz Association between abnormal respiratory clinical signs and respiratory localization in dogs and cats
10.00 Le Boedec Association between tomodensitometry, rhinoscopy, and histopathology characteristics and treatment response in canine idiopathic rhinitis
10.15 Gori Pulmonary complications in canine acute pancreatitis: a pilot study
11.20 Griebsch Effectiveness of aspirin versus clopidogrel in dogs with immune mediated haemolytic anaemia evaluated by serial thromboelastography and platelet mapping
11.35 Whittemore Platelet function in healthy dogs receiving sustained clopidogrel, prednisone, or combination therapy
11.50 Black Retrospective analysis of presentation and diagnosis in 115 referred juvenile dogs presenting with pyrexia
12.05 Banzato Development of a frailty index to assess the risk of mortality in the dog
ISCAID - International Society for Companion Animal Infectious Diseases
Friday 7 September 2018
12.20 Felten Prevalence of feline coronavirus shedding and associated risk factors in catteries
12.35 Beatty Novel hepatitis B-like hepadnavirus identified in a feline immunodeficiency virus-infected domestic cat
14.25 de Jong Long-term follow-up and prognostic factors in canine leishmaniasis in a non-endemic country, a retrospective cohort study
14.40 Francey Reduction in incidence of canine leptospirosis in Switzerland correlates with the introduction of a new quadrivalent anti-leptospiral vaccine
14.55 López Leptospira seroprevalence in owned dogs from Spain
15.10 Dorsch Urine shedding of pathogenic Leptospira spp. in cats in Southern Chile
15.25 Schmitt Patterns of antimicrobial use for selected feline diseases in Switzerland in 2016
ESVNU – European Society of Veterinary Nephrology and Urology
Friday 7 September 2018
14.25 Lourenco Inflammatory and pro-fibrotic pathway upregulation in an ischemic model of feline chronic kidney disease
14.40 Menard Symmetric Dymethylarginine evaluation and characterization of proteinuria in dogs with pituitary-dependant hyperadrenocorticism
14.55 McKenna The clinical utility of glomerular filtration rate measurement in dogs
15.10 Lamoureux In vitro antimicrobial susceptibility patterns of urinary bacterial isolates in dogs with chronic kidney disease
15.25 Marques Dogs as reservoirs of uropathogenic Klebsiella pneumoniae to humans
15.40 Pastor Urolithiasis prevalence in leishmania infantum-infected dogs treated with allopurinol in an endemic area of the South of France
16.30 Schweighauser Evaluation of prescription, anticoagulation, and metabolic response to membrane-based therapeutic plasma exchange in dogs
16.45 Ogeer Comparative Performance of IDEXX SDMA® Test and the DLD SDMA ELISA for the Measurement of SDMA in Canine and Feline Serum
17.00 Butty Ultrasound-guided subcutaneous ureteral bypass and microsurgical ureterotomy in cats with obstructive ureterolith
17.15 Olivares The utility of charcoal bacteriology swabs for storage of urine prior to culture
ESCG – European Society of Comparative Gastroenterology
Friday 7 September 2018
14.25 Da Riz Are clinical and paraclinical data helpful in discriminating feline low-grade alimentary lymphoma from inflammatory bowel disease?  A prospective study of 36 cases
14.40 Freiche Histopathological and molecular characterisation of feline low-grade alimentary lymphoma and inflammatory bowel disease:  a prospective analysis of 36 cases
14.55 Berman Hypoalbuminaemia as a possible biomarker of gastro-intestinal lymphoma in cats
15.10 Werner Treatment of Dogs with Acute Uncomplicated Diarrhea with Amoxicillin Clavulanate: A Prospective, Placebo-controlled, Randomized, Blinded Treatment Trial
15.25 Burchell Faecal microbial transplantation in a  canine model of haemorrhagic diarrhoea syndrome
15.40 Ziese Longitudinal Assessment of Clostridium perfringens encoding NetF toxin in Dogs with Acute Haemorrhagic Diarrhoea Syndrome
16.30 Whittemore Gastrointestinal changes in healthy dogs receiving sustained clopidogrel, prednisone, or combination therapy
16.45 Whittemore Antibiotic-associated gastrointestinal signs in healthy dogs administered antibiotics with or without synbiotics
17.00 Jergens Glucocorticoid effects on microbial community structure in canine inflammatory bowel disease
17.15 Cabrera Garcia Decreased serum soluble rage concentrations correlate with the severity of histologic lesions in dogs with chronic inflammatory enteropathies
17.30 Febo Evaluation of plasma endocannabinoids in dogs with primary chronic enteropathies
17.45 Salavati Schmitz Retrospective analysis of dogs with inflammatory protein-losing enteropathy reveals that second-line immunosuppression is only necessary in 1/3 of cases and treatment requirements or outcome cannot be predicted by routine clinicopathological data
ESVE – European Society of Veterinary Endocrinology
Friday 7 September 2018
14.25 Peterson Radioiodine treatment of feline hyperthyroidism: measuring 24-hour thyroid 131-I uptake helps predict treatment failure or development of iatrogenic hypothyroidism
14.40 Fabres Evaluation of telmisartan administration as a suppression test for primary hyperaldosteronism diagnosis in cats
14.55 Ferri Pheochromocytoma in dogs undergoing adrenalectomy: an exploratory investigation of 24 cases
15.10 Petroff Temporal changes in thyroid status in euthyroid dogs with positive thyroglobulin autoantibodies
15.25 Del Baldo Validation of human immunoturbidimetric assays for the measurement of glycated hemoglobin (HbA1c) and serum fructosamine in dogs and comparison of the two variables for the assessment of glycemic control in dogs with diabetes mellitus
15.40 Hazuchova Effect of monthly injections of GLP-1 analogue exenatide extended release on ß-cell function in newly diagnosed diabetic cats
15.55 Ferri Thyroidectomy in dogs with thyroid tumors: survival analysis in 99 cases (1994-2013)
Saturday 8 September 2018
14.40 Bennaim A visual aid to judgement in the diagnosis of canine hyperadrenocorticism and the development of a diagnosis score
14.55 Hazuchova Functional impact of single nucleotide polymorphisms within the putative promoter of feline ACP1 gene in lean Domestic Shorthair cats with diabetes mellitus
15.25 Prasinou The erythrocyte membrane lipidome profile in healthy dogs and changes in dogs with diabetes mellitus
15.40 Blomqvist Presence of T- and B-lymphocytes in the canine pituitary gland
16.30 Schuppisser Comparison of continuous glucose monitoring profiles and glycemic variability during day and night in healthy and diabetic cats
16.45 Ramsey Haptoglobin and pre-trilostane cortisol as monitoring tools for the treatment of canine hyperadrenocorticism
17.00 Peterson Spontaneous primary hypothyroidism in adult cats: More common that we think?
17.15 Buresova Short- and long-term follow-up of kidney function using creatinine, SDMA and GFR in hyperthyroid cats treated with radioiodine
ESVCP – European Society of Veterinary Clinical Pathology
Saturday 8 September 2018
09.45 Dröes Circannual variation in standardized haematological and biochemical markers in dogs
10.00 Bilbrough Frequency of clinically significant abnormal biochemistry profiles in adult dogs and cats presenting to North American veterinary practices for wellness examinations
10.15 Le Boedec Determination of reference intervals from small samples: how to enhance estimation accuracy
11.20 Tangalidi Evaluation of the paraoxonase-1 concentration in dogs with mitral valve disease.
11.35 Prieto Biological Variation of Symmetric Dimethylarginine and Other Biochemical Analytes in Healthy Cats
11.50 De Witte Corrected calcium as a predictor of hypocalcaemia in hypoalbuminaemic dogs
12.05 Hope Evaluation of the clinical utility of a point-of-care serum amyloid A (SAA) assay for the detection of inflammatory disease in dogs
12.20 Davison Targeted serum metabolomic and lipidomic profiling in Miniature Schnauzers – a pilot study
12.35 Klainbart Acute organophosphate and carbamate intoxication in 102 dogs - a retrospective study
VBPS - Veterinary Blood Pressure Society  
Saturday 8 September 2018
11.20 Ioannidi Comparison of systolic arterial blood pressure between low stress and common handling conditions in cats using the Doppler method and High Definition Oscillometry
11.35 Archontakis Comparison of Doppler ultrasonography and oscillometry with or without proprietary optimizations for non-invasive blood pressure measurement in conscious cats
11.50 Archontakis Comparison of two Doppler ultrasonography devices for measurement of systolic blood pressure in conscious dogs
ESVCN – European Society of Veterinary Comparative  Nutrition
Saturday 8 September 2018
15.50 Mazaki Tovi Arachidonic acid stimulates secretion of IL6 in feline primary adipose tissue culture